Two poster presentations will highlight research on the effects of paracentesis and CKD in adults with HRS-AKI1,2- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in patients with hepatorenal syndrome-acute kidney injury (HRS-AKI), at Kidney Week 2025, the annual meeting of the American Society of Nephrology (ASN), […]

C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 Manulife Financial Corporation will release its third quarter 2025 financial results after markets close on Wednesday, November 12, 2025, which will be made available at manulife.com/en/investors/results-and-reports. https://mma.prnewswire.com/media/2807480/Manulife_Financial_Corporation_Manulife_to_Release_Third_Quarter.jpg Awebcast and conference call are scheduled for Thursday, November 13, 2025, at 8:00 a.m. (ET) where members of Manulife's executive

Sirona Medical today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona Advanced Imaging Suite, marking a significant regulatory milestone and the company's first Class II medical device designation. https://mma.prnewswire.com/media/1949755/Sirona_Logo.jpg This clearance expands Sirona's diagnostic imaging capabilities to include PET-CT support with quantitative SUV analysis, image fusion, maximum

Merigold and Log10 partner to apply Everest's AI technology to the multibillion-dollar imaging clinical trials market, debuting Bloom AI at AMWA 2025 to showcase faster, more accurate documentation and study start-up. Merigold, a leader in imaging trial documentation, has partnered with Log10, creator of Everest, the AI platform for life sciences services, to bring automation

Following strong results with Blue Cross NC, Prime and Sempre expand availability of affordability and adherence solutions to commercial clients nationwide Prime Therapeutics LLC (Prime), a pharmacy solutions organization focused on delivering savings, simplicity, and support, is expanding access to behavior-based medication pricing through a nationwide engagement with Sempre Health (Sempre). This strategic initiative strengthens

Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows: Conference call details:Date: November 6, 2025Time: 8:30 a.m. ETURL to register phone: Register HereDial-in number: (888) 880-3330

In partnership with ForgiveCo, the veteran-owned brands are pledging 100% of profits Veterans Day weekend to eliminate a financial burden for thousands of American heroes This Veterans Day weekend, Born Primitive and Black Rifle Coffee Company, in partnership withForgiveCo, are uniting under one powerful mission: to eliminate up to $25 million in medical debt for

Seasoned Investment Professional Joins to Support the Continued Growth of the AEA Elevate Platform AEA Investors (“AEA” or the “Firm”), a leading global private investment firm,today announced that Abraham Zilkha has joined the Firm as a Partner on the AEA Elevate team. In this role, Mr. Zilkha will serve as a member of the AEA

S&P Global Inc. (NYSE: SPGI) will host an Investor Day on November 13, 2025 in New York City. Martina Cheung, President and Chief Executive Officer, will be joined by Eric Aboaf, Chief Financial Officer, and other senior leaders. They expect to discuss S&P Global's strategy, with specific focus on go-to-market initiatives and technology, and provide

Arrow Financial Corporation (NasdaqGS® – AROW) (“Arrow” or “the Company”) announced financial results for the three-month period ended September 30, 2025. Reported net income for the third quarter of 2025 was $12.8 million and fully diluted earnings per share (“EPS”) was $0.77, versus net income of $10.8 million and EPS of $0.65 for the second